My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

112.09 +1.23 (+1.11%)
Streaming Delayed Price Updated: 12:49 PM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Gilead Sciences

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
45 46 Next >
Gilead Squashes Expectations On The Back Of A Bullish Move For Its Cancer Drugs
The biotech company makes three notable treatments for cancer. 
Via Investor's Business Daily
Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical Activity
Gilead Sciences Inc (NASDAQ: GILD) and Arcus Biosciences Inc (NYSE: RCUS) announced that domvanalimab plus zimberelimab and chemotherapy showed encouraging overall response rate (ORR) and six-month... 
Via Benzinga
S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto
Sentiment appears to have dipped after a six-session winning streak. Stock futures indicate a modestly lower opening on Tuesday as small and mid-cap earnings reports gain momentum. 
Via Benzinga
Topics Economy Stocks
If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,200 Today
 
Via Benzinga
This Is What Whales Are Betting On Gilead Sciences
 
Via Benzinga
Comparative Study: Gilead Sciences And Industry Competitors In Biotechnology Industry
 
Via Benzinga
Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
 
Via Benzinga
Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets
Markets bounced back decisively this week, shrugging off prior volatile months marked by heightened geopolitical tensions. The resurgence of risk sentiment ignited a relief rally in both equities and... 
Via Benzinga
Topics Bonds Economy
Leidos Sees Robust Demand In Digital Modernization, Raises Annual Outlook
Leidos Holdings, Inc (NYSE: LDOS) reported third-quarter FY23 revenue growth of 9% year-over-year to $3.92 billion, beating the consensus of $3.77 billion.  
Via Benzinga
3 Pharma Stocks That Are Screaming Buys in October
Each company delivers an above-average dividend and revenue growth. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
 
Via Benzinga
How Is The Market Feeling About Gilead Sciences?
 
Via Benzinga
7 Healthcare Stocks to invest in for a Healthy Future
Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners. 
Via InvestorPlace
Pfizer Decides To Raise COVID-19 Treatment Pill Price, Defends Itself Amid Criticism for Cost Increase
Pfizer Inc (NYSE: PFE) is reportedly gearing up to price its Covid-19 drug Paxlovid at $1,390 for a five-day course, more than double what the U.S. government initially paid for it, at $529.  
Via Benzinga
Vertex Pharmaceuticals, Gilead Sciences And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower by over 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Why AstraZeneca's Disappointing Lung Cancer Update Also Tripped Gilead Stock
The companies are hoping to use antibody drug conjugates in lung cancer patients. 
Via Investor's Business Daily
Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?
Assembly Biosciences stock is taking off with heavy trading of ASMB shares after the company announced a new collaboration agreement! 
Via InvestorPlace
Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why
Gilead Sciences Inc (NASDAQ: GILD) and Assembly Biosciences Inc (NASDAQ: ASMB) have entered into a 12-year partnership. 
Via Benzinga
2 Dirt Cheap High-Yield Dividend Stocks to Buy Right Now
These companies aren't getting the respect they deserve. 
Via The Motley Fool
A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip
Wall Street price targets suggest this stock can rocket more than 400% higher. 
Via The Motley Fool
Biotech Sector: On The Verge Of Triumph Or Turmoil?
In this article, we delve into the Biotech Sector, exploring its promises, potential pitfalls, and the questions that arise. 
Via Talk Markets
Pharma Giants Combine Forces to Fight New M&A Rules
Some of pharma's biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms. 
Via The Motley Fool
Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs
CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T. 
Via InvestorPlace
3 Magnificent Dividend Stocks to Buy in October
These stocks come with great dividends and more. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Two Trial Halts In A Row - Gilead Sciences Stops Late Stage COVID-19 Study
Gilead Sciences Inc (NASDAQ: GILD) said it has  
Via Benzinga
Gilead Sciences Adapts to Economic Shifts to Support Investor Confidence
By the end of today, September 28, 2023, Gilead Sciences (NASDAQ:GILD) is set to deliver a dividend payout of $0.75 per share, equating to an annualized dividend yield of 3.96%. 
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Many stocks have nosebleed valuations. But not these. 
Via The Motley Fool
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.